Tesamorelin vs Ipamorelin: How Researchers Choose
Two receptors, two pulse shapes. When each peptide is studied on its own vs as a blended stack.
Tesamorelin and Ipamorelin both increase GH release in preclinical models, but they do it through different receptors and produce very different pulse shapes. Understanding that difference is the fastest way to pick the right peptide for a given experimental design.
1. Different receptors, different signals
- Tesamorelin: A stabilized GHRH analog. Binds GHRH-R on somatotroph cells and drives cAMP-dependent GH synthesis and release. Increases the amplitude of GH pulses and has been characterized for effects on visceral adiposity in published human clinical trials (referenced here as literature only).
- Ipamorelin: A selective GHS-R1a (ghrelin receptor) agonist. Suppresses somatostatin tone, permitting more frequent GH pulses, with minimal effect on cortisol, prolactin, or ACTH at typical study concentrations.
2. Side-by-side
| Property | Tesamorelin · Ipamorelin |
|---|---|
| Receptor | GHRH-R · GHS-R1a |
| Pulse effect | Amplitude · Frequency |
| Structure | 44 aa GHRH analog · 5 aa pentapeptide |
| Cortisol/prolactin | Minimal · Minimal |
| Study frequency (typical) | Once daily · 1–3× daily |
3. Why researchers stack them
Because Tesamorelin increases how much GH is released per pulse and Ipamorelin increases how often those pulses fire, a blended vial has been used in preclinical designs to model a more physiological GH profile than either peptide alone. Vertex Peptides supplies a co-lyophilized Tesamorelin / Ipamorelin blend for this reason.
4. Quality checklist
- Purity: ≥ 99% HPLC with mass-spec identity, batch-specific, third-party.
- Reconstitution: Bacteriostatic water; aliquot post-reconstitution to avoid freeze-thaw damage.
- Storage: Lyophilized 2–8 °C. Reconstituted refrigerated, protected from light, used within 30 days.
Ready to source it?
Every peptide referenced in this guide ships with a batch-specific third-party COA.